Ruchira Papers Ltd. is a Public Limited Listed company incorporated on 08/12/1980 and has its registered office in the State of Himachal Pradesh, India. Company’s Corporate Identification Number(CIN) is L21012HP1980PLC004336 and registration number is 004336. Currently Company is involved in the business activities of Manufacture of paper and paper products. Company’s Total Operating Revenue is Rs. 612.86 Cr. and Equity Capital is Rs. 25.20 Cr. for the Year ended 31/03/2022.
INDUSTRY
ADDRESS
CONTACT
Paper & Paper Products
Trilokpur Road, Kala Amb, Sirmour District Himachal Pradesh 173030
Below is a detailed analysis of the quarterly data for Fundamental Analysis of Ruchira Papers Ltd based on the most recent figures (Sep 2023) and their trends compared to the previous period:
For Sales, as of Sep 2023, the value is ₹170.00 Cr.. The value appears strong and on an upward trend. It has increased from 169.00 Cr. (Jun 2023) to ₹170.00 Cr., marking an increase of ₹1.00 Cr..
For Expenses, as of Sep 2023, the value is ₹151.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 135.00 Cr. (Jun 2023) to ₹151.00 Cr., marking an increase of ₹16.00 Cr..
For Operating Profit, as of Sep 2023, the value is ₹19.00 Cr.. The value appears to be declining and may need further review. It has decreased from 34.00 Cr. (Jun 2023) to ₹19.00 Cr., marking a decrease of 15.00 Cr..
For OPM %, as of Sep 2023, the value is 11.00%. The value appears to be declining and may need further review. It has decreased from 20.00% (Jun 2023) to 11.00%, marking a decrease of 9.00%.
For Other Income, as of Sep 2023, the value is ₹1.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Jun 2023) to ₹1.00 Cr., marking an increase of ₹1.00 Cr..
For Interest, as of Sep 2023, the value is ₹1.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2023) which recorded 1.00 Cr..
For Depreciation, as of Sep 2023, the value is ₹4.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2023) which recorded 4.00 Cr..
For Profit before tax, as of Sep 2023, the value is ₹14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 29.00 Cr. (Jun 2023) to ₹14.00 Cr., marking a decrease of 15.00 Cr..
For Tax %, as of Sep 2023, the value is 25.00%. The value remains steady. There is no change compared to the previous period (Jun 2023) which recorded 25.00%.
For Net Profit, as of Sep 2023, the value is ₹11.00 Cr.. The value appears to be declining and may need further review. It has decreased from 22.00 Cr. (Jun 2023) to ₹11.00 Cr., marking a decrease of 11.00 Cr..
For EPS in Rs, as of Sep 2023, the value is 3.55. The value appears to be declining and may need further review. It has decreased from ₹7.29 (Jun 2023) to 3.55, marking a decrease of ₹3.74.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
×
Ruchira Papers Ltd Quarterly Chart
Ruchira Papers Ltd Profit & Loss
Last Updated: Unknown
Metric
Mar 2012
Mar 2013
Mar 2014
Mar 2015
Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
TTM
Sales
283
296
318
345
361
416
447
494
481
415
613
803
678
Expenses
242
245
270
306
313
352
373
412
437
390
549
694
582
Operating Profit
40
51
49
39
47
64
74
82
44
25
64
109
96
OPM %
14%
17%
15%
11%
13%
15%
17%
17%
9%
6%
10%
14%
14%
Other Income
1
2
2
1
1
1
4
1
2
1
1
2
2
Interest
20
17
14
10
7
8
8
8
7
6
6
5
4
Depreciation
11
11
12
10
10
11
12
13
14
14
14
15
16
Profit before tax
11
25
25
20
32
46
58
62
25
6
45
91
78
Tax %
34%
33%
40%
37%
39%
30%
35%
36%
-9%
19%
26%
25%
Net Profit
8
16
15
13
19
32
38
40
27
5
33
68
58
EPS in Rs
3.07
6.66
6.19
5.19
7.88
13.16
15.39
15.07
10.25
1.87
11.95
22.66
19.58
Dividend Payout %
0%
14%
18%
23%
17%
16%
13%
14%
0%
49%
15%
22%
×
Ruchira Papers Ltd Profit & Loss Yearly Chart
Ruchira Papers Ltd Growth
Compounded Sales Growth
10 Years:
8%
5 Years:
6%
3 Years:
17%
TTM:
-3%
Compounded Profit Growth
10 Years:
12%
5 Years:
4%
3 Years:
115%
TTM:
0%
Stock Price CAGR
10 Years:
16%
5 Years:
30%
3 Years:
14%
1 Year:
-6%
Return on Equity
10 Years:
14%
5 Years:
12%
3 Years:
15%
Last Year:
12%
Last Updated: Unknown
Ruchira Papers Ltd Balance Sheet
Last Updated: Unknown
Month
Mar 2012
Mar 2013
Mar 2014
Mar 2015
Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Sep 2023
Equity Capital
22
22
22
22
22
22
22
24
24
24
25
30
30
Reserves
48
61
74
83
98
130
169
220
240
246
281
351
382
Borrowings
124
106
93
71
73
61
88
75
68
76
66
42
29
Other Liabilities
53
61
67
70
74
87
86
92
69
68
87
86
87
Total Liabilities
248
251
256
247
267
300
366
411
401
414
460
508
528
Fixed Assets
162
156
152
148
173
178
228
231
234
235
251
296
291
CWIP
-0
0
-0
1
-0
3
3
3
5
30
27
4
6
Investments
-0
-0
-0
-0
-0
-0
-0
-0
-0
-0
-0
-0
-0
Other Assets
86
95
103
98
94
119
136
177
162
149
182
208
232
Total Assets
248
251
256
247
267
300
366
411
401
414
460
508
528
Below is a detailed analysis of the balance sheet data for Fundamental Analysis of Ruchira Papers Ltd based on the most recent figures (Sep 2023) and their trends compared to the previous period:
For Equity Capital, as of Sep 2023, the value is ₹30.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2023) which recorded ₹30.00 Cr..
For Reserves, as of Sep 2023, the value is ₹382.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹351.00 Cr. (Mar 2023) to ₹382.00 Cr., marking an increase of 31.00 Cr..
For Borrowings, as of Sep 2023, the value is ₹29.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from ₹42.00 Cr. (Mar 2023) to ₹29.00 Cr., marking a decrease of 13.00 Cr..
For Other Liabilities, as of Sep 2023, the value is ₹87.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹86.00 Cr. (Mar 2023) to ₹87.00 Cr., marking an increase of 1.00 Cr..
For Total Liabilities, as of Sep 2023, the value is ₹528.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹508.00 Cr. (Mar 2023) to ₹528.00 Cr., marking an increase of 20.00 Cr..
For Fixed Assets, as of Sep 2023, the value is ₹291.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹296.00 Cr. (Mar 2023) to ₹291.00 Cr., marking a decrease of 5.00 Cr..
For CWIP, as of Sep 2023, the value is ₹6.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹4.00 Cr. (Mar 2023) to ₹6.00 Cr., marking an increase of 2.00 Cr..
For Investments, as of Sep 2023, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2023) which recorded ₹0.00 Cr..
For Other Assets, as of Sep 2023, the value is ₹232.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹208.00 Cr. (Mar 2023) to ₹232.00 Cr., marking an increase of 24.00 Cr..
For Total Assets, as of Sep 2023, the value is ₹528.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹508.00 Cr. (Mar 2023) to ₹528.00 Cr., marking an increase of 20.00 Cr..
Notably, the Reserves (₹382.00 Cr.) exceed the Borrowings (29.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
After reviewing the key financial ratios for Fundamental Analysis of Ruchira Papers Ltd, here is a detailed analysis based on the latest available data and recent trends:
For FaceValue, as of Mar 23, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 22) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 23, the value is 22.66. This value is within the healthy range. It has increased from 13.13 (Mar 22) to 22.66, marking an increase of 9.53.
For Diluted EPS (Rs.), as of Mar 23, the value is 22.66. This value is within the healthy range. It has increased from 12.89 (Mar 22) to 22.66, marking an increase of 9.77.
For Cash EPS (Rs.), as of Mar 23, the value is 27.78. This value is within the healthy range. It has increased from 18.86 (Mar 22) to 27.78, marking an increase of 8.92.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 23, the value is 127.48. It has increased from 122.83 (Mar 22) to 127.48, marking an increase of 4.65.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 23, the value is 127.48. It has increased from 122.83 (Mar 22) to 127.48, marking an increase of 4.65.
For Dividend / Share (Rs.), as of Mar 23, the value is 5.00. This value exceeds the healthy maximum of 3. It has increased from 2.00 (Mar 22) to 5.00, marking an increase of 3.00.
For Revenue From Operations / Share (Rs.), as of Mar 23, the value is 268.96. It has increased from 243.16 (Mar 22) to 268.96, marking an increase of 25.80.
For PBDIT / Share (Rs.), as of Mar 23, the value is 37.17. This value is within the healthy range. It has increased from 25.82 (Mar 22) to 37.17, marking an increase of 11.35.
For PBIT / Share (Rs.), as of Mar 23, the value is 32.06. This value is within the healthy range. It has increased from 20.09 (Mar 22) to 32.06, marking an increase of 11.97.
For PBT / Share (Rs.), as of Mar 23, the value is 30.37. This value is within the healthy range. It has increased from 17.67 (Mar 22) to 30.37, marking an increase of 12.70.
For Net Profit / Share (Rs.), as of Mar 23, the value is 22.66. This value is within the healthy range. It has increased from 13.13 (Mar 22) to 22.66, marking an increase of 9.53.
For PBDIT Margin (%), as of Mar 23, the value is 13.82. This value is within the healthy range. It has increased from 10.61 (Mar 22) to 13.82, marking an increase of 3.21.
For PBIT Margin (%), as of Mar 23, the value is 11.91. This value is within the healthy range. It has increased from 8.26 (Mar 22) to 11.91, marking an increase of 3.65.
For PBT Margin (%), as of Mar 23, the value is 11.29. This value is within the healthy range. It has increased from 7.26 (Mar 22) to 11.29, marking an increase of 4.03.
For Net Profit Margin (%), as of Mar 23, the value is 8.42. This value is within the healthy range. It has increased from 5.39 (Mar 22) to 8.42, marking an increase of 3.03.
For Return on Networth / Equity (%), as of Mar 23, the value is 17.77. This value is within the healthy range. It has increased from 10.68 (Mar 22) to 17.77, marking an increase of 7.09.
For Return on Capital Employeed (%), as of Mar 23, the value is 22.86. This value is within the healthy range. It has increased from 14.18 (Mar 22) to 22.86, marking an increase of 8.68.
For Return On Assets (%), as of Mar 23, the value is 13.30. This value is within the healthy range. It has increased from 7.19 (Mar 22) to 13.30, marking an increase of 6.11.
For Long Term Debt / Equity (X), as of Mar 23, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.03 (Mar 22) to 0.00, marking a decrease of 0.03.
For Total Debt / Equity (X), as of Mar 23, the value is 0.11. This value is within the healthy range. It has decreased from 0.18 (Mar 22) to 0.11, marking a decrease of 0.07.
For Asset Turnover Ratio (%), as of Mar 23, the value is 1.66. It has increased from 1.40 (Mar 22) to 1.66, marking an increase of 0.26.
For Current Ratio (X), as of Mar 23, the value is 2.31. This value is within the healthy range. It has increased from 1.77 (Mar 22) to 2.31, marking an increase of 0.54.
For Quick Ratio (X), as of Mar 23, the value is 1.34. This value is within the healthy range. It has increased from 0.85 (Mar 22) to 1.34, marking an increase of 0.49.
For Inventory Turnover Ratio (X), as of Mar 23, the value is 6.29. This value is within the healthy range. It has increased from 5.37 (Mar 22) to 6.29, marking an increase of 0.92.
For Dividend Payout Ratio (NP) (%), as of Mar 23, the value is 8.02. This value is below the healthy minimum of 20. It has increased from 7.32 (Mar 22) to 8.02, marking an increase of 0.70.
For Dividend Payout Ratio (CP) (%), as of Mar 23, the value is 6.54. This value is below the healthy minimum of 20. It has increased from 5.10 (Mar 22) to 6.54, marking an increase of 1.44.
For Earning Retention Ratio (%), as of Mar 23, the value is 91.98. This value exceeds the healthy maximum of 70. It has decreased from 92.68 (Mar 22) to 91.98, marking a decrease of 0.70.
For Cash Earning Retention Ratio (%), as of Mar 23, the value is 93.46. This value exceeds the healthy maximum of 70. It has decreased from 94.90 (Mar 22) to 93.46, marking a decrease of 1.44.
For Interest Coverage Ratio (X), as of Mar 23, the value is 22.08. This value is within the healthy range. It has increased from 10.68 (Mar 22) to 22.08, marking an increase of 11.40.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 23, the value is 14.46. This value is within the healthy range. It has increased from 6.43 (Mar 22) to 14.46, marking an increase of 8.03.
For Enterprise Value (Cr.), as of Mar 23, the value is 320.26. It has decreased from 345.49 (Mar 22) to 320.26, marking a decrease of 25.23.
For EV / Net Operating Revenue (X), as of Mar 23, the value is 0.39. This value is below the healthy minimum of 1. It has decreased from 0.56 (Mar 22) to 0.39, marking a decrease of 0.17.
For EV / EBITDA (X), as of Mar 23, the value is 2.89. This value is below the healthy minimum of 5. It has decreased from 5.31 (Mar 22) to 2.89, marking a decrease of 2.42.
For MarketCap / Net Operating Revenue (X), as of Mar 23, the value is 0.34. This value is below the healthy minimum of 1. It has decreased from 0.47 (Mar 22) to 0.34, marking a decrease of 0.13.
For Retention Ratios (%), as of Mar 23, the value is 91.97. This value exceeds the healthy maximum of 70. It has decreased from 92.67 (Mar 22) to 91.97, marking a decrease of 0.70.
For Price / BV (X), as of Mar 23, the value is 0.73. This value is below the healthy minimum of 1. It has decreased from 0.93 (Mar 22) to 0.73, marking a decrease of 0.20.
For Price / Net Operating Revenue (X), as of Mar 23, the value is 0.34. This value is below the healthy minimum of 1. It has decreased from 0.47 (Mar 22) to 0.34, marking a decrease of 0.13.
For EarningsYield, as of Mar 23, the value is 0.24. This value is below the healthy minimum of 5. It has increased from 0.11 (Mar 22) to 0.24, marking an increase of 0.13.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
×
Ruchira Papers Ltd Profitability Ratios (%)
Ruchira Papers Ltd Liquidity Ratios
Ruchira Papers Ltd Liquidity Ratios (%)
Ruchira Papers Ltd Interest Coverage Ratios (X)
Ruchira Papers Ltd Valuation Ratios
Fair Value
Fair Value of as of March 12, 2025 is: ₹132.01
Calculation basis:
Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.
As of March 12, 2025, is Overvalued by 1.49% compared to the current share price 134.00
Intrinsic Value of as of March 12, 2025 is: 150.25
Calculation basis:
Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.
This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.
As of March 12, 2025, is Undervalued by 12.13% compared to the current share price 134.00
Last 5 Year EPS CAGR: 13.82%
*Investments are subject to market risks
Strength and Weakness of Ruchira Papers Ltd
Strength
Weakness
The stock has a high average ROCE of 18.92%, which is a positive sign.
The company has higher reserves (183.31 cr) compared to borrowings (74.77 cr), indicating strong financial stability.
The company has shown consistent growth in sales (457.69 cr) and profit (40.31 cr) over the years.
The stock has a high average Working Capital Days of 69.50, which may not be favorable.
The stock has a high average Cash Conversion Cycle of 97.58, which may not be favorable.
Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in :
Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
ROE%: 17.77% (Industry Average ROE: 12.57%)
ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
Stock P/E: 5.85 (Industry average Stock P/E: 29.32)
Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
Total Debt / Equity: 0.11
Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions. Stock Rating: